Vanguard Global Advisers »

Alaunos Therapeutics shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of Alaunos Therapeutics (TCRT) shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in Alaunos Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Alaunos Therapeutics held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alaunos Therapeutics by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.4k 501 2.86

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)

View all positions for Vanguard Global Advisers

Top funds holding Alaunos Therapeutics

Vanguard Group
Geode Capital Management
BlackRock
Vanguard Fiduciary Trust
Vanguard Capital Management
Hrt Financial
Two Sigma Investments
Citadel Advisors
UBS Group
Tower Research Capital
Advisor Group Holdings
Morgan Stanley
Vanguard Global Advisers
Atlantic Trust
Wells Fargo & Company

View all funds holding Alaunos Therapeutics